With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients

With drug Empagliflozin going off patent, doctors look forward to price reduction, benefitting diabetic, heart and kidney patients

Doctors are expecting a drastic reduction in the price of the drug, enabling them to prescribe it to more patients Doctors are expecting a drastic reduction in the price of the drug, enabling them to prescribe it to more patients Health Health News, Wellbeing Tips, Diseases, Treatment and Nutrition | The Hindu

Leave a Reply

Your email address will not be published. Required fields are marked *